Synesthesia as the Rule of Perception: Toward a Hyper-Dialectical Pedagogy in Art Education
Visual Arts Research · 01.12.2026 · 52 (2) · 34-46
DOI: 10.5406/21518009.52.2.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Visual Arts Research, online erschienen am 01.12.2026. Verfasst von Li Xu. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Synesthesia is commonly understood as a phenomenon where senses blend and overlap with each other. Drawing on Maurice Merleau-Ponty's phenomenology of perception, this paper reconceptualizes synesthesia not as an anomaly, but as a fundamental structure of perception. In this framework, synesthesia reveals the intersensory and relational nature of perception and illuminates the hyper-dialectical dimension of body, which underlies flesh as an ontological condition in Merleau-Ponty's phenomenology. By integrating theoretical analysis and pedagogical practice, this paper argues that synesthesia offers a productive framework for rethinking perception and embodiment in art education. It further develops a synesthetic pedagogy that cultivates awareness of synesthetic experience, suspends habitual modes of perception, and engages cross-sensory transformation as a basis for creative activity. In doing so, this phenomenological approach supports more relational and inclusive learning environments that foreground the diversity of lived experience.
Zitieren
APA
Xu, L. (2026). Synesthesia as the Rule of Perception: Toward a Hyper-Dialectical Pedagogy in Art Education. Visual Arts Research, 52(2), 34-46. https://doi.org/10.5406/21518009.52.2.04
Vancouver
Xu L. Synesthesia as the Rule of Perception: Toward a Hyper-Dialectical Pedagogy in Art Education. Visual Arts Research. 2026;52(2):34-46. doi:10.5406/21518009.52.2.04
BibTeX
@article{Xu2026,
author = {Xu, Li},
title = {Synesthesia as the Rule of Perception: Toward a Hyper-Dialectical Pedagogy in Art Education},
journal = {Visual Arts Research},
year = {2026},
volume = {52},
number = {2},
pages = {34--46},
doi = {10.5406/21518009.52.2.04}
}
EUVIMED